Search results
Showing 4201 to 4250 of 8897 results
Home What NICE does NICE International {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1
We work with the clinical classifications service of NHS Digital to provide relevant clinical coding information for interventional procedure and medical technologies guidance.
These are the main stages in the multiple technology appraisal process used before April 2018.
Our Medical Technologies Evaluation Programme (MTEP) evaluates new HealthTech.
The key stages in development of our quality standards
Consultation on changes to technology appraisals and highly specialised technologies
Home What NICE does Our guidance About technology appraisal guidance Our methods and processes (health technology evaluation manual) Methods and...
Home What NICE does Our guidance About interventional procedures guidance {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElem
We use 3 processes for assessing technologies: the single technology appraisal, the multiple technology appraisal and the cost comparison appraisal
Our forward view highlights the topics we will prioritise in the coming year.
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Services for older people {"@context":"http://schema.org"
NICE guidance and standards support health professionals by providing evidence-based recommendations that enhance clinical decision-making and patient care.
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios for principle social workers Positive workplaces for social
Our board sets out our strategic priorities and policies. It has 2 sub-committees, the audit and risk assurance committee and the remuneration committee.
We're working with colleagues to ensure that virtual wards are used in a way that maximises the value for patients and the NHS.
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
Epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancer (HTG714)
Evidence-based recommendations on epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancer. This involves radioactive paste being spread on foil over the top of the cancer, to destroy the cancer cells.
View recommendations for HTG714Show all sections
Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care (HTG607)
Evidence-based recommendations on Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care.
Biographies and registered interests for members of the Technology Appraisal Committee A
Details and meeting dates of the antimicrobials evaluation panel
Membership details, terms of reference and future meeting dates for our quality standards advisory committee.
Membership details, terms of reference, future meeting dates and past meeting minutes for our indicator advisory committee.
Read biographies of the members of our quality standards advisory committee.
Home Get involved Our committees NICE committee meetings...
Membership details, terms of reference, future meeting dates and past meeting minutes for our 4 technology appraisal committees.
More detail about Medical Technologies Advisory Committee (MTAC) registration, meeting arrangements and types of attendee.
Evidence-based recommendations on endoscopic radiofrequency ablation for Barrett’s oesophagus with low-grade dysplasia or no dysplasia. This involves using radiofrequency (heat) energy to destroy the abnormal cells and promote the growth of healthy normal cells.
Evidence-based recommendations on photochemical corneal cross linkage using riboflavin and ultraviolet A for keratoconus. This involves using special eye drops and exposing the eye ultraviolet light, with the aim to strengthen the cornea.
Selective internal radiation therapy for primary hepatocellular carcinoma (HTG314)
Evidence-based recommendations on selective internal radiation therapy (SIRT) for primary hepatocellular carcinoma. This involves infusion of microspheres loaded with yttrium-90, which aims to deliver radiation directly into the tumour, minimising the risk of radiation damage to healthy surrounding tissues.
View recommendations for HTG314Show all sections
Sections for HTG314
Evidence-based recommendations on the ReCell Spray-On Skin system for treating skin loss, scarring and depigmentation after burn injury.
E‑vita open plus for treating complex aneurysms and dissections of the thoracic aorta (HTG326)
Evidence-based recommendations on the E-vita open plus for treating complex aneurysms and dissections of the thoracic aorta.
Evidence-based recommendations on therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors (LISA-TRACKER, IDKmonitor and Promonitor ELISA kits) in people with Crohn’s disease.
Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment (HTG360)
Evidence-based recommendations on the My5-FU assay for measuring levels of 5-flurouracil (5-FU) in patients having chemotherapy, to help guide changes to the dose of 5-FU.
More detail about Diagnostics Advisory Committee (DAC) registration, meeting arrangements and types of attendee.
Home Get involved Our committees NICE committee meetings...
Find out more about NICE technology appraisals advisory committee D members
Biographies for all current members of the diagnostics advisory committee.
Membership details, terms of reference, future meeting dates and past meeting minutes for our diagnostics advisory committee.
Biographies and registered interests for members of the Technology Appraisal Committee C
Membership details, terms of reference, future meeting dates and past meeting minutes for our interventional procedures advisory committee.
Highly specialised technologies evaluation committee members
Biographies for each member of the highly specialised technologies evaluation committee.
Read the biographies for all members of the NICE antimicrobial evaluation committee.
Read biographies for all members of NICE's indicator advisory committee.
Find out more about the NICE technology appraisal advisory committee B members and their registered interests
Evidence-based recommendations on Alpha-Stim AID for managing anxiety disorders.
Devices for remote monitoring of Parkinson's disease (HTG657)
Evidence-based recommendations on Kinesia 360 and KinesiaU (Great Lakes NeuroTechnologies), PDMonitor (PD Neurotechnology), Personal KinetiGraph (Global Kinetics) and STAT-ON (Sense4care) for remote monitoring of Parkinson’s disease.
PLGF-based testing to help diagnose suspected preterm pre-eclampsia (HTG630)
Evidence-based recommendations on placental growth factor (PLGF)-based testing to help diagnose suspected preterm pre-eclampsia. The tests are: DELFIA Xpress PLGF 1-2-3, DELFIA Xpress sFlt-1/PLGF 1-2-3 ratio, Elecsys immunoassay sFlt-1/PLGF ratio, Triage PLGF Test.
Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis (HTG521)
Evidence-based recommendations on enzyme-linked immunosorbent assay (ELISA) tests for therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors in rheumatoid arthritis. The tests are Promonitor, IDKmonitor, LISA-tracker, RIDASCREEN, MabTrack, and those used by Sanquin Diagnostic Services.
Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolism (HTG376)
Evidence-based recommendations on ultrasound enhanced catheter-directed thrombolysis for pulmonary embolism. This involves using ultrasound waves and a drug to break up the clot.
Ultrasound‑enhanced, catheter‑directed thrombolysis for deep vein thrombosis (HTG375)
Evidence-based recommendations on ultrasound enhanced catheter-directed thrombolysis for deep vein thrombosis. This involves using ultrasound waves and a drug to break up the clot.
Evidence-based recommendations on single incision laparoscopic cholecystectomy. This involves removing the gallbladder through a small cut, most often below the bellly button.